175 related articles for article (PubMed ID: 8812832)
1. Expression and characterization of cysteine-modified variants of an amino-terminal fragment of bactericidal/permeability-increasing protein.
Horwitz AH; Leigh SD; Abrahamson S; Gazzano-Santoro H; Liu PS; Williams RE; Carroll SF; Theofan G
Protein Expr Purif; 1996 Aug; 8(1):28-40. PubMed ID: 8812832
[TBL] [Abstract][Full Text] [Related]
2. rBPI(10-193) is secreted by CHO cells and retains the activity of rBPI21.
Horwitz AH; Ammons WS; Bauer RJ; Dedrick R; Nadell R; Williams RE; Liu PS
J Endotoxin Res; 2004; 10(2):97-106. PubMed ID: 15120000
[TBL] [Abstract][Full Text] [Related]
3. Inclusion of S-sepharose beads in the culture medium significantly improves recovery of secreted rBPI(21) from transfected CHO-K1 cells.
Horwitz AH; Carroll SF; Williams RE; Liu PS
Protein Expr Purif; 2000 Feb; 18(1):77-85. PubMed ID: 10648172
[TBL] [Abstract][Full Text] [Related]
4. Both N- and C-terminal regions of the bioactive N-terminal fragment of the neutrophil granule bactericidal/permeability-increasing protein are required for stability and function.
Capodici C; Weiss J
J Immunol; 1996 Jun; 156(12):4789-96. PubMed ID: 8648126
[TBL] [Abstract][Full Text] [Related]
5. Cysteine 230 modulates tumor necrosis factor-related apoptosis-inducing ligand activity.
Seol DW; Billiar TR
Cancer Res; 2000 Jun; 60(12):3152-4. PubMed ID: 10866303
[TBL] [Abstract][Full Text] [Related]
6. The recombinant C-terminus of the human MUC2 mucin forms dimers in Chinese-hamster ovary cells and heterodimers with full-length MUC2 in LS 174T cells.
Lidell ME; Johansson ME; Mörgelin M; Asker N; Gum JR; Kim YS; Hansson GC
Biochem J; 2003 Jun; 372(Pt 2):335-45. PubMed ID: 12597771
[TBL] [Abstract][Full Text] [Related]
7. Structural requirements for intracellular processing and sorting of bactericidal/permeability-increasing protein (BPI): comparison with lipopolysaccharide-binding protein.
Bülow E; Gullberg U; Olsson I
J Leukoc Biol; 2000 Nov; 68(5):669-78. PubMed ID: 11073106
[TBL] [Abstract][Full Text] [Related]
8. Interchangeable endotoxin-binding domains in proteins with opposite lipopolysaccharide-dependent activities.
Schumann RR; Lamping N; Hoess A
J Immunol; 1997 Dec; 159(11):5599-605. PubMed ID: 9548502
[TBL] [Abstract][Full Text] [Related]
9. Determination of tumor necrosis factor binding protein disulfide structure: deviation of the fourth domain structure from the TNFR/NGFR family cysteine-rich region signature.
Jones MD; Hunt J; Liu JL; Patterson SD; Kohno T; Lu HS
Biochemistry; 1997 Dec; 36(48):14914-23. PubMed ID: 9398215
[TBL] [Abstract][Full Text] [Related]
10. Competition between rBPI23, a recombinant fragment of bactericidal/permeability-increasing protein, and lipopolysaccharide (LPS)-binding protein for binding to LPS and gram-negative bacteria.
Gazzano-Santoro H; Mészáros K; Birr C; Carroll SF; Theofan G; Horwitz AH; Lim E; Aberle S; Kasler H; Parent JB
Infect Immun; 1994 Apr; 62(4):1185-91. PubMed ID: 8132325
[TBL] [Abstract][Full Text] [Related]
11. [Gene cloning and expression of human bactericidal/permeability-increasing protein].
Xu J; Xu J; Wang H
Wei Sheng Wu Xue Bao; 2001 Dec; 41(6):669-73. PubMed ID: 12552821
[TBL] [Abstract][Full Text] [Related]
12. Expression, purification, and characterization of a murine CD4 fragment containing the first two N-terminal domains.
Wang WC; Yeh AA
Biochem Biophys Res Commun; 1997 Nov; 240(3):530-5. PubMed ID: 9398598
[TBL] [Abstract][Full Text] [Related]
13. Disulfide structure and N-glycosylation sites of an extracellular domain of granulocyte-colony stimulating factor receptor.
Haniu M; Horan T; Arakawa T; Le J; Katta V; Hara S; Rohde MF
Biochemistry; 1996 Oct; 35(40):13040-6. PubMed ID: 8855939
[TBL] [Abstract][Full Text] [Related]
14. Importance of cysteine residues for the stability and catalytic activity of human pancreatic beta cell glucokinase.
Tiedge M; Richter T; Lenzen S
Arch Biochem Biophys; 2000 Mar; 375(2):251-60. PubMed ID: 10700381
[TBL] [Abstract][Full Text] [Related]
15. Characterization of free alpha- and beta-chains of recombinant macrophage-stimulating protein.
Yoshikawa W; Hara H; Takehara T; Shimonishi M; Sakai H; Shimizu N; Shimizu S; Wang MH; Hagiya M; Skeel A; Leonard EJ
Arch Biochem Biophys; 1999 Mar; 363(2):356-60. PubMed ID: 10068459
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo characterization of disulfide bond use in myocilin complex formation.
Fautsch MP; Vrabel AM; Peterson SL; Johnson DH
Mol Vis; 2004 Jun; 10():417-25. PubMed ID: 15235575
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of bactericidal/permeability-increasing protein (BPI) analogues on retinal neovascularization and retinal pericyte growth.
Rauniyar RK; Suzuma K; King AL; Aiello LP; King GL
Invest Ophthalmol Vis Sci; 2002 Feb; 43(2):503-9. PubMed ID: 11818397
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of lipid A-mediated type I interferon induction by bactericidal/permeability-increasing protein (BPI).
Azuma M; Matsuo A; Fujimoto Y; Fukase K; Hazeki K; Hazeki O; Matsumoto M; Seya T
Biochem Biophys Res Commun; 2007 Mar; 354(2):574-8. PubMed ID: 17239348
[TBL] [Abstract][Full Text] [Related]
19. Functional significance of cysteine residues in the delta opioid receptor studied by site-directed mutagenesis.
Ehrlich GK; Andria ML; Zheng X; Kieffer B; Gioannini TL; Hiller JM; Rosenkranz JE; Veksler BM; Zukin RS; Simon EJ
Can J Physiol Pharmacol; 1998 Mar; 76(3):269-77. PubMed ID: 9673790
[TBL] [Abstract][Full Text] [Related]
20. The bactericidal/permeability increasing protein of neutrophils is a potent antibacterial and anti-endotoxin agent in vitro and in vivo.
Elsbach P; Weiss J; Doerfler M; Shu C; Kohn F; Ammons WS; Kung AH; Meszaros KK; Parent JB
Prog Clin Biol Res; 1994; 388():41-51. PubMed ID: 7831373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
